Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.identifier.citationGrech, F. (2018). Legalising marijuana for medical purposes : costs and benefits (Bachelor’s dissertation).en_GB
dc.description.abstractThis dissertation assesses the net economic benefits or otherwise of a policy improving patients’ quality of life, through a Cost-Benefit Analysis. The policy comprises of legalising marijuana for medical purposes in Malta. This study makes use of high-level expert advice, international studies and local secondary data to estimate the costs and benefits of the policy suggested. Consequently, this study calculates threeseparate economic benefits namely improved quality of life for three groups of patients – Cancer, Pain Conditions and Tourette’s Syndrome. An exercise to analyse the regulatory and patient-incurred-costs was carried out in order to obtain a comprehensive Benefit-Cost comparison. The results achieved indicate an outstandingly positive Benefit-Cost ratio.This implies that the legalisation of marijuana for medical purposes would be valuable for society. In general, the average improvement in quality of life, mainly obtained from patients suffering from pain conditions, outweighed the costs associated with treatment costs and the regulation of the market. A sensitivity analysis was conducted in the case of a negative shock on the most significant benefit and it was concluded that the model under considerationis robustenoughto significant shocks. This furthermorejustifiesthe legalising of medical marijuana. Health status as well as quality of life are both major determinants for a society to prosper and are becoming increasingly important with economic growth and development. This dissertation is based on this premise and shows howthe policy under considerationisbeneficial to society at large since significant economic benefits result in comparison to costs incurred. Thus, it is important for Government to focus on the increasing society’s economic benefits rather than stopping at Financial Net Present Value calculation which would limit the actual return on investment and social implication of any emerging requirement.en_GB
dc.subjectMarijuana -- Therapeutic use -- Maltaen_GB
dc.subjectMarijuana -- Therapeutic use -- Law and legislation -- Maltaen_GB
dc.subjectQuality of life -- Maltaen_GB
dc.subjectDrug legalization -- Maltaen_GB
dc.subjectCost effectivenessen_GB
dc.titleLegalising marijuana for medical purposes : costs and benefitsen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.publisher.institutionUniversity of Maltaen_GB
dc.publisher.departmentFaculty of Economics, Management and Accountancy. Department of Economicsen_GB
dc.contributor.creatorGrech, Francesca-
Appears in Collections:Dissertations - FacEma - 2018
Dissertations - FacEMAEco - 2018

Files in This Item:
File Description SizeFormat 
  Restricted Access
1 MBAdobe PDFView/Open Request a copy

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.